Abiopharma

🔍 DICKSON RICHARD (Director)

Company: GAP INC (GAP)

Report Date: 2026-08-22

Detailed Transactions and Holdings:

• Acquired 109,649 shares of Common Stock (Direct)
  Date: 2026-08-22 | Code: M | equity_swap_involved: 0 | shares_owned_after: 796,060.35 | transaction_form_type: 4
• Sold 59,155 shares of Common Stock at $19.8 per share (Direct)
  Date: 2026-08-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 736,905.35 | transaction_form_type: 4
• Acquired 116,502 shares of Common Stock (Direct)
  Date: 2026-08-22 | Code: M | equity_swap_involved: 0 | shares_owned_after: 853,407.35 | transaction_form_type: 4
• Sold 62,852 shares of Common Stock at $19.8 per share (Direct)
  Date: 2026-08-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 790,555.35 | transaction_form_type: 4
• Sold 109,649 shares of Restricted Stock Unit (Derivative)
  Date: 2026-08-22 | Code: M | equity_swap_involved: 0 | shares_owned_after: 607,691.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Sold 116,502 shares of Restricted Stock Unit (Derivative)
  Date: 2026-08-22 | Code: M | equity_swap_involved: 0 | shares_owned_after: 491,189.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of Gap Inc. Common Stock.
• F2: On August 22, 2023, the reporting person was granted 438,596 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
• F3: On August 22, 2023, the reporting person was granted 466,008 restricted stock units, vesting fifty percent of the total grant on the first anniversary of the grant date, twenty-five percent on the second anniversary of the grant date, and the remaining twenty-five percent on the third anniversary of the grant date.